TLPH Q4 2017 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$740,000-88.5% YoY

Gross Profit

-$4M-526.8% margin

Operating Income

-$8M-1055.0% margin

Net Income

-$10M-1335.8% margin

EPS (Diluted)

$-3.92

QoQ Revenue Growth

-50.2%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$76M

Total Liabilities

$112M

Stockholders' Equity

-$37M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$740,000	$6M	-88.5%
Gross Profit	-$4M	-$3M	-27.4%
Operating Income	-$8M	-$7M	-9.4%
Net Income	-$10M	-$10M	-2.1%